오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - prilocaine hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.54 microgram/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - indications as at 23 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block tecniques.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - felypressin; prilocaine hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.03 iu/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; acetic acid; sodium acetate; chlorobutanol hemihydrate; sodium hydroxide - citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

미국 - 영어 - NLM (National Library of Medicine)

dentsply pharmaceutical inc. - prilocaine hydrochloride (unii: mjw015baph) (prilocaine - unii:046o35d44r) - prilocaine hydrochloride 40 mg in 1 ml - 4% citanest plain dental injection, prilocaine hydrochloride injection, usp, 4% (72 mg/1.8 ml) (40 mg/ml), is indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques. only accepted procedures for these techniques as described in standard textbooks are recommended. prilocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type and in those rare patients with congenital or idiopathic methemoglobinemia.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

dentsply (australia) pty ltd - prilocaine hydrochloride -

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - prilocaine hydrochloride - solution for injection - 10mg/1ml

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

dentsply detrey gmbh - felypressin; prilocaine hydrochloride - solution for injection - 3 %w/v +0.54 microgram(s)/millilitre - amides; prilocaine, combinations

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - felypressin 0.54 µg/ml; prilocaine hydrochloride 3% (30mg/ml.);   - solution for injection - active: felypressin 0.54 µg/ml prilocaine hydrochloride 3% (30mg/ml.)   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - infiltration anaesthesia in dentistry, where there is no need for profound ischaemia in the injected area.

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - prilocaine hydrochloride - solution for injection - 10mg/1ml